28.8 C
New York
Sunday, June 14, 2026

Tag: laboratory

Microbiome Sequencing Market on the Rise: 19.3% CAGR Forecast

"Driving Innovation Across Healthcare, Agriculture, and Environmental Science, Microbiome Sequencing Unlocks the Power of Microbial DNA to Enable Personalized Medicine, Sustainable Farming, and Ecosystem...

Nootropics Depot’s Tongkat Ali Declared Most Cost-Efficient and Potent in Industry, According to Independent Lab Tests

TEMPE, Ariz., Aug. 4, 2025 /PRNewswire/ -- New independent UPLC laboratory testing has confirmed that Nootropics Depot's Tongkat Ali extracts are the industry's leading...

BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care

FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to...

SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS

IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, formerly known as the PULS™ Cardiac Test, is now more accessible than ever for patients in the northeastern United States.

Sirona Biochem Update to Shareholders on Financial Status and Operations

VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (“Sirona”) wishes to provide shareholders with a critical update on the company’s financial position and recent corporate developments.

CNL and Partners Identified Three Canadian Locations to Advance the Design of Renewable Diesel Production Facilities

Leveraging the feasibility results from the NRCan-funded project, the project team is now aiming to complete the front-end engineering design for three facilities to convert wood waste feedstock into renewable diesel fuel
Leveraging the feasibility results from the NRCan-funded project, the project team is now aiming to complete the front-end engineering design for three facilities to convert wood waste feedstock into renewable diesel fuel

Xtalks Announces its Life Science Webinar Calendar for August 2025

Upcoming free, educational webinars from Xtalks will feature topics on cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, healthcare, laboratory...

EarthEn Energy Launches Breakthrough Heat Battery at RE+ Storage to Decarbonize Industrial Heat Processes

PHOENIX, Aug. 1, 2025 /PRNewswire/ -- EarthEn Energy, a climate-tech innovator in long-duration energy storage (LDES), proudly launched its EarthEn Heat Battery at RE+ Storage, Santa Clara,...

Avantor® Reports Second Quarter 2025 Results

Net sales of $1.68 billion, decrease of 1%; organic revenue was flatNet income of $65 million; Adjusted EBITDA of $280 millionDiluted GAAP EPS of...

Clinisys acquires Orchard Software

Strategic acquisition strengthens Clinisys's leadership in laboratory informatics across the full spectrum of healthcare, life sciences, and public health. BANGALORE, India and TUCSON, Ariz., Aug. 1,...

LUNDIN GOLD REPORTS EXCEPTIONAL DRILLING RESULTS AT FDNS AND FDN EAST WITH FDNS ADVANCING TOWARDS INTEGRATION INTO MINE PLAN

VANCOUVER, BC, July 31, 2025 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased...

Precipio Announces Q2-2025 Shareholder Update Call

Conference Call to be held on August 14th, 2025 at 5:00 PM EST
Conference Call to be held on August 14th, 2025 at 5:00 PM EST

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced second quarter 2025 financial results and provided a corporate update.

NCS Multistage to Acquire ResMetrics, Further Expanding Tracer Diagnostics Offering

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (“NCS” or the “Company”) today announced that it has acquired ResMetrics LLC (“ResMetrics”), a leading provider of chemical tracer diagnostics services used by oil and gas operators to validate reservoir development strategies, improve hydraulic fracture stimulation designs, evaluate inter-well connectivity, and optimize enhanced oil recovery injection programs, complementing and further strengthening NCS’s tracer diagnostics capabilities.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLaboratory